Proactive Investors - Run By Investors For Investors

Medlab Clinical accelerating VMS business in Australia, and NanaBis globally

Medlab Clinical Ltd (ASX:MDC) managing director & CEO Sean Hall catches up with Proactive Investors about the biotech's progress so far in 2019.

Hall teases, "We're planning on having around about 3000 pharmacies utilising the Medlab VMS range before this calendar year is out."

Progress is also being made with the NanoCelle drug delivery platform. Clinical and human trials are ongoing for NanaBis and NanoStat. On the back of this, Medlab has been making strong moves into Europe.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
View full MDC profile View Profile

Medlab Clinical Ltd Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use